Search Results - "Himmelsbach, Ruth"

Immune changes induced by periampullary adenocarcinoma are reversed after tumor resection and modulate the postoperative survival by Landerer, Anna, Himmelsbach, Ruth, Biesel, Esther A., Fichtner-Feigl, Stefan, Wittel, Uwe A., Chikhladze, Sophia

“…Background Tumor growth encompasses multiple immunologic processes leading to impaired immunity. Regarding cancer surgery, the perioperative period is…”
Get full text

PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study by Reimold, Philipp, Tosev, Georgi, Kaczorowski, Adam, Friedhoff, Jana, Schwab, Constantin, Schütz, Viktoria, Görtz, Magdalena, Panzer, Niklas, Heller, Martina, Aksoy, Cem, Himmelsbach, Ruth, Walle, Thomas, Zschäbitz, Stefanie, Jäger, Dirk, Duensing, Anette, Stenzinger, Albrecht, Hohenfellner, Markus, Duensing, Stefan

“…Renal cell carcinoma (RCC) is among the most lethal urologic malignancies once metastatic. Current treatment approaches for metastatic RCC (mRCC) involve…”
Get full text

Re: Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort by Hohenfellner, Markus, Himmelsbach, Ruth

Get full text

Retrospective analysis of the learning curve in perineal robot-assisted prostate biopsy by Himmelsbach, Ruth, Hackländer, Alexander, Weishaar, Moritz, Morlock, Jonathan, Schoeb, Dominik, Jilg, Cordula, Gratzke, Christian, Grabbert, Markus, Sigle, August

“…Magnetic resonance imaging-transrectal ultrasound (MRI-TRUS)-fusion biopsy (FBx) of the prostate allows targeted sampling of suspicious lesions within the…”
Get full text

SALVAGE RADIOTHERAPY IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PSA PERSISTENCE OR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY DUE TO PROSTATE CANCER by Grabbert, Markus, Zamboglou, Constantinos, Spohn, Simon, Jilg, Cordula, Sigle, August, Himmelsbach, Ruth, Liakos, Nikolaos, Astheimer, Sophie, Schäfer, Henning, Sprave, Tanja, Grosu, Anca-Ligia, Gratzke, Christian

“…The combination of immunotherapy (IO) with radiation therapy might provide a clinical benefit to our patients due to a synergistic effect. Radiation therapy of…”
Get full text

Immunological effects of hybrid minimally invasive versus conventional open pancreatoduodenectomy - A single center cohort study by Himmelsbach, Ruth, Landerer, Anna, Hipp, Julian, Hopt, Ulrich T., Fichtner-Feigl, Stefan, Wittel, Uwe A., Ruess, Dietrich A.

“…Minimally invasive surgery is a field of rapid development. Evidence from randomized controlled trials in visceral surgery however still falls short of…”
Get full text

Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer by Nientiedt, Cathleen, Budczies, Jan, Endris, Volker, Kirchner, Martina, Schwab, Constantin, Jurcic, Christina, Behnisch, Rouven, Hoveida, Shirin, Lantwin, Philippa, Kaczorowski, Adam, Geisler, Christine, Dieffenbacher, Svenja, Falkenbach, Fabian, Franke, Desiree, Görtz, Magdalena, Heller, Martina, Himmelsbach, Ruth, Pecqueux, Carine, Rath, Mathias, Reimold, Philipp, Schütz, Viktoria, Simunovic, Iva, Walter, Elena, Hofer, Luisa, Gasch, Claudia, Schönberg, Gita, Pursche, Lars, Hatiboglu, Gencay, Nyarangi-Dix, Joanne, Sültmann, Holger, Zschäbitz, Stefanie, Koerber, Stefan A., Jäger, Dirk, Debus, Jürgen, Duensing, Anette, Schirmacher, Peter, Hohenfellner, Markus, Stenzinger, Albrecht, Duensing, Stefan

“…•We show that a substantial proportion of patients undergoing RPX for localized high-risk or locally advanced prostate cancer harbor mutations in DNA damage…”
Get full text